HELP     Sign In
Search

Relevance to Autism

Recurrent mutations in the GRIN2B gene have been identified in multiple individuals with ASD as described below. Myers et al. (2011) found an excess of rare non-synonymous mutations in GRIN2B in both autism and schizophrenia cases (PMID 21383861). O'Roak et al., 2011 identified an ASD proband from a simplex family with a de novo splice-site variant in GRIN2B; three additional de novo loss-of-function variants in GRIN2B were identified in ASD probands from simplex families in two subsequent reports from O'Roak and colleagues in 2012 (PMIDs 22495309 and 23160955). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) in De Rubeis et al., 2014 identified GRIN2B as a gene meeting high statistical significance with a FDR 0.01, meaning that this gene had a 99% chance of being a true autism gene (PMID 25363760). This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017). A two-stage analysis of rare de novo and inherited coding variants in 42,607 ASD cases, including 35,130 new cases from the SPARK cohort, in Zhou et al., 2022 identified GRIN2B as a gene reaching exome-wide significance (P < 2.5E-06). Platzer et al., 2017 evaluated 48 novel and 43 previously published individuals with de novo GRIN2B variants; 13 of the 48 novel individuals in this report were reported to have ASD as a phenotype (PMID 28377535). Yoo et al. (2012) showed association of GRIN2B markers in a Korean ASD cohort of 151 families (PMID 22326929); other studies have also found genetic association of the GRIN2B gene with schizophrenia (Ohtsuki et al., 2001) and obsessive-compulsive disorder (Arnold et al., 2004).

Molecular Function

NMDA receptor subtype of glutamate-gated ion channels with high calcium permeability and voltage-dependent sensitivity to magnesium.

External Links

        

References

Type
Title
Type of Disorder
Associated Disorders
Author, Year
Primary
Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations.
ASD
Positive Association
Association of genetic variants of GRIN2B with autism.
ASD
Positive Association
A candidate gene association study further corroborates involvement of contactin genes in autism.
ASD
Positive Association
De novo mutations in epileptic encephalopathies.
Epilepsy
IS, LGS, DD, ID, ASD, ADHD
Positive Association
Family based association of GRIN2A and GRIN2B with Korean autism spectrum disorders.
ASD
Support
Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundaries.
ASD
Support
An autism-associated mutation in GluN2B prevents NMDA receptor trafficking and interferes with dendrite growth.
ASD
Support
Targeted sequencing identifies 91 neurodevelopmental-disorder risk genes with autism and developmental-disability biases.
ASD, DD
Support
Integrating de novo and inherited variants in 42
ASD
Support
GRIN2B mutations in West syndrome and intellectual disability with focal epilepsy.
Epilepsy, ID
Autistic behavior
Support
Confirming the contribution and genetic spectrum of de novo mutation in infantile spasms: Evidence from a Chinese cohort
Epilepsy/seizures
ASD, DD
Support
Diagnostic exome sequencing of syndromic epilepsy patients in clinical practice.
DD, epilepsy/seizures, microcephaly
Support
Meta-analysis of 2,104 trios provides support for 10 new genes for intellectual disability
ID
Support
Genetic Analysis of Children With Unexplained Developmental Delay and/or Intellectual Disability by Whole-Exome Sequencing
DD, ID
Support
Exome sequencing of ion channel genes reveals complex profiles confounding personal risk assessment in epilepsy.
Epilepsy
Support
Exome sequencing of 457 autism families recruited online provides evidence for autism risk genes
ASD
Support
DD, epilepsy/seizures
Support
Molecular Mechanism of Disease-Associated Mutations in the Pre-M1 Helix of NMDA Receptors and Potential Rescue Pharmacology.
Support
Monogenic developmental and epileptic encephalopathies of infancy and childhood
DD, ID, epilepsy/seizures
Support
Excess of rare novel loss-of-function variants in synaptic genes in schizophrenia and autism spectrum disorders.
ASD, SCZ
Support
The landscape of somatic mutation in cerebral cortex of autistic and neurotypical individuals revealed by ultra-deep whole-genome sequencing
ASD
Support
Rates, distribution and implications of postzygotic mosaic mutations in autism spectrum disorder.
ASD
Support
DD, ID
ADHD, epilepsy/seizures
Support
Gene Mutation Analysis in 253 Chinese Children with Unexplained Epilepsy and Intellectual/Developmental Disabilities.
DD, ID, epilepsy/seizures
Support
Prevalence and phenotypic impact of rare potentially damaging variants in autism spectrum disorder
ASD
Support
Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes.
ID
Support
De novo GRIN variants in NMDA receptor M2 channel pore-forming loop are associated with neurological diseases.
Support
DD
Autistic features, stereotypy
Support
Whole-Genome Sequencing of Cytogenetically Balanced Chromosome Translocations Identifies Potentially Pathological Gene Disruptions and Highlights t...
ASD, ID, epilepsy/seizures
Support
Genetic and Phenotype Analysis of a Chinese Cohort of Infants and Children With Epilepsy
Epilepsy/seizures
DD
Support
Interstitial 12p13.1 deletion involving GRIN2B in three patients with intellectual disability.
ID
ASD, Epilepsy
Support
Large-scale targeted sequencing identifies risk genes for neurodevelopmental disorders
ASD, DD
ID
Support
Genomic diagnosis for children with intellectual disability and/or developmental delay.
ID
Hypotonia, macrocephaly
Support
Large-scale discovery of novel genetic causes of developmental disorders.
DD
Support
A single center experience with publicly funded clinical exome sequencing for neurodevelopmental disorders or multiple congenital anomalies
DD, ID, epilepsy/seizures
Stereotypy
Support
Impact of on-site clinical genetics consultations on diagnostic rate in children and young adults with autism spectrum disorder.
ASD
Support
ASD
DD, ID
Support
Clinical exome sequencing: results from 2819 samples reflecting 1000 families.
ID, delayed speech and language development, motor
ASD
Support
Overlapping cortical malformations in patients with pathogenic variants in GRIN1 and GRIN2B
DD, epilepsy/seizures
Support
Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders.
ASD
Support
Genetic landscape of autism spectrum disorder in Vietnamese children
ASD
Support
Next-generation DNA sequencing identifies novel gene variants and pathways involved in specific language impairment.
Specific language impairment
Support
Recurrent de novo mutations implicate novel genes underlying simplex autism risk.
ASD
Support
An Autism-Associated de novo Mutation in GluN2B Destabilizes Growing Dendrites by Promoting Retraction and Pruning
ASD
Support
Characterization of intellectual disability and autism comorbidity through gene panel sequencing.
ID, ASD or autistic traits
Support
The genomic landscape of balanced cytogenetic abnormalities associated with human congenital anomalies.
ASD
Support
Two new cases of nonepileptic neurodevelopmental disorder due to GRIN2B variants and detailed clinical description of the behavioral phenotype
DD
Stereotypy
Support
Diagnostic exome sequencing in persons with severe intellectual disability.
ID
Epilepsy, ASD
Support
Rare genetic susceptibility variants assessment in autism spectrum disorder: detection rate and practical use.
ASD
Support
A clinical utility study of exome sequencing versus conventional genetic testing in pediatric neurology.
Epilepsy/seizures
Psychomotor retardation
Support
Depressive disorder, anxiety disorder, epilepsy/se
Support
De novo mutations in moderate or severe intellectual disability.
ID
Microcephaly, absent speech
Support
Clinical and genetic spectrum of 104 Indian families with central nervous system white matter abnormalities
White matter abnormalities
DD
Support
Atypical Rett Syndrome and Intractable Epilepsy With Novel GRIN2B Mutation.
Epilepsy/seizures, developmental stagnation/regres
Stereotypies
Support
De novo genic mutations among a Chinese autism spectrum disorder cohort.
ASD
Support
The GluN2B-Trp373 NMDA Receptor Variant is Associated with Autism-, Epilepsy-Related Phenotypes and Reduces NMDA Receptor Currents in Rats
ASD, ID, epilepsy/seizures
Support
Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and schizophrenia.
ASD, SCZ
Support
Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism
ASD
Support
A Rare Variant Identified Within the GluN2B C-Terminus in a Patient with Autism Affects NMDA Receptor Surface Expression and Spine Density.
Support
Disruption of grin2B, an ASD-associated gene, produces social deficits in zebrafish
ASD
Support
Three rare diseases in one Sib pair: RAI1, PCK1, GRIN2B mutations associated with Smith-Magenis Syndrome, cytosolic PEPCK deficiency and NMDA recep...
DD, ID
Hypoglycemia, lactic acidosis
Support
Genome sequencing of 320 Chinese children with epilepsy: a clinical and molecular study
ASD, DD, epilepsy/seizures
Support
Disease-associated missense mutations in GluN2B subunit alter NMDA receptor ligand binding and ion channel properties.
Support
Mutation screening of GRIN2B in schizophrenia and autism spectrum disorder in a Japanese population.
ASD, SCZ
Support
Rare variants in the outcome of social skills group training for autism
ASD
Highly Cited
Mutation analysis of the NMDAR2B (GRIN2B) gene in schizophrenia.
SCZ
Highly Cited
Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obsessive-compulsive disorder: a preliminary study.
OCD
Recent Recommendation
Neuronal excitation upregulates Tbr1, a high-confidence risk gene of autism, mediating Grin2b expression in the adult brain.
Recent Recommendation
Disruption of GRIN2B Impairs Differentiation in Human Neurons.
Recent Recommendation
Behavioral phenotype in five individuals with de novo mutations within the GRIN2B gene.
ID
Recent Recommendation
Surface Expression, Function, and Pharmacology of Disease-Associated Mutations in the Membrane Domain of the Human GluN2B Subunit.
Recent Recommendation
A population genetic approach to mapping neurological disorder genes using deep resequencing.
ASD, SCZ
Recent Recommendation
GRIN2B encephalopathy: novel findings on phenotype, variant clustering, functional consequences and treatment aspects.
Epilepsy/seizures
DD, ID, ASD
Recent Recommendation
Strain dependent effects of prenatal stress on gene expression in the rat hippocampus.
Recent Recommendation
Mechanistic Insight into NMDA Receptor Dysregulation by Rare Variants in the GluN2A and GluN2B Agonist Binding Domains.
Epilepsy/seizures, DD
Recent Recommendation
Direct measure of the de novo mutation rate in autism and schizophrenia cohorts.
SCZ
Recent Recommendation
Low load for disruptive mutations in autism genes and their biased transmission.
ASD
Recent Recommendation
Synaptic, transcriptional and chromatin genes disrupted in autism.
ASD
Recent Recommendation
ASD

Rare

Variant ID
Variant Type
Allele Change
Residue Change
Inheritance Pattern
Inheritance Association
Family Type
Author, Year
 GEN111R001 
 splice_site_variant 
 c.2172-2A>G 
  
 De novo 
  
 Simplex 
 GEN111R002 
 inversion 
  
  
 De novo 
  
  
 GEN111R003 
 missense_variant 
 T>G 
 p.Leu825Val 
 De novo 
  
  
 GEN111R004 
 synonymous_variant 
 c.834C>A 
 p.Ile278= 
 Unknown 
  
 Unknown 
 GEN111R005 
 synonymous_variant 
 c.1440G>A 
 p.Leu480= 
 Unknown 
  
 Unknown 
 GEN111R006 
 synonymous_variant 
 c.4107C>T 
 p.Gly1369= 
 Unknown 
  
 Unknown 
 GEN111R007 
 missense_variant 
 c.731C>T 
 p.Ala244Val 
 Unknown 
  
 Unknown 
 GEN111R008 
 missense_variant 
 c.1658C>T 
 p.Pro553Leu 
 De novo 
  
  
 GEN111R009 
 stop_gained 
 c.1677G>A 
 p.Trp559Ter 
 De novo 
  
 Simplex 
 GEN111R010 
 missense_variant 
 c.1367G>A 
 p.Cys456Tyr 
 De novo 
  
 Simplex 
 GEN111R011 
 frameshift_variant 
 c.99dup 
 p.Ser34GlnfsTer25 
 De novo 
  
 Simplex 
 GEN111R012 
 missense_variant 
 c.2473T>G 
 p.Leu825Val 
 De novo 
  
 Simplex 
 GEN111R013 
 missense_variant 
 c.3076G>A 
 p.Gly1026Ser 
  
  
  
 GEN111R014 
 missense_variant 
 c.4244C>T 
 p.Ser1415Leu 
  
  
  
 GEN111R015 
 copy_number_loss 
  
  
 De novo 
  
  
 GEN111R016 
 copy_number_loss 
  
  
 De novo 
  
  
 GEN111R017 
 copy_number_loss 
  
  
 De novo 
  
  
 GEN111R018 
 missense_variant 
 c.1382G>T 
 p.Cys461Phe 
 De novo 
  
  
 GEN111R019 
 translocation 
  
  
 De novo 
  
  
 GEN111R020 
 translocation 
  
  
 De novo 
  
  
 GEN111R021 
 splice_site_variant 
 c.411+1G>A 
  
 De novo 
  
  
 GEN111R022 
 missense_variant 
 c.2044C>T 
 p.Arg682Cys 
 De novo 
  
  
 GEN111R023 
 splice_site_variant 
 c.2360-2A>G 
  
 De novo 
  
  
 GEN111R024 
 frameshift_variant 
 c.803_804del 
 p.Thr268SerfsTer15 
 De novo 
  
  
 GEN111R025 
 missense_variant 
 c.1906G>C 
 p.Ala636Pro 
 De novo 
  
  
 GEN111R026 
 stop_gained 
 c.2131C>T 
 p.Gln711Ter 
 De novo 
  
  
 GEN111R027 
 missense_variant 
 c.1853T>G 
 p.Val618Gly 
 De novo 
  
  
 GEN111R028 
 missense_variant 
 c.1844A>T 
 p.Asn615Ile 
 De novo 
  
  
 GEN111R029 
 missense_variant 
 c.1619G>A 
 p.Arg540His 
 De novo 
  
  
 GEN111R030 
 splice_site_variant 
 c.2011-5_2011-4del 
  
 Familial 
 Paternal 
  
 GEN111R031 
 frameshift_variant 
 c.2594del 
 p.Ser865ThrfsTer19 
 Unknown 
  
 Unknown 
 GEN111R032 
 frameshift_variant 
 c.13del 
 p.Ala5ArgfsTer67 
 Unknown 
  
 Unknown 
 GEN111R033 
 stop_gained 
 c.1555C>T 
 p.Arg519Ter 
 Unknown 
  
 Unknown 
 GEN111R034 
 missense_variant 
 c.2087G>A 
 p.Arg696His 
 Unknown 
  
 Unknown 
 GEN111R035 
 missense_variant 
 c.1619G>A 
 p.Arg540His 
 Unknown 
  
 Unknown 
 GEN111R036 
 missense_variant 
 c.3242G>A 
 p.Arg1081His 
 Unknown 
  
 Unknown 
 GEN111R037 
 missense_variant 
 c.2459G>C 
 p.Gly820Ala 
 De novo 
  
 Simplex 
 GEN111R038 
 synonymous_variant 
 c.2793C>T 
 p.Val931= 
 Unknown 
  
 Simplex 
 GEN111R039 
 synonymous_variant 
 c.2877C>T 
 p.Phe959= 
 Unknown 
  
 Simplex 
 GEN111R040 
 synonymous_variant 
 c.3429A>G 
 p.Ser1143= 
 Unknown 
  
 Simplex 
 GEN111R041 
 synonymous_variant 
 c.3564C>G 
 p.Gly1188= 
 Unknown 
  
 Simplex 
 GEN111R042 
 missense_variant 
 c.3683C>T 
 p.Thr1228Met 
 Unknown 
  
 Simplex 
 GEN111R043 
 missense_variant 
 c.4015A>G 
 p.Met1339Val 
 Familial 
 Paternal 
 Simplex 
 GEN111R044 
 missense_variant 
 c.3818C>A 
 p.Thr1273Lys 
 Familial 
 Paternal 
 Simplex 
 GEN111R045 
 missense_variant 
 c.1985A>C 
 p.Gln662Pro 
 De novo 
  
 Simplex 
 GEN111R046 
 missense_variant 
 c.1672G>A 
 p.Val558Ile 
 De novo 
  
  
 GEN111R047 
 missense_variant 
 c.1570G>A 
 p.Asp524Asn 
 De novo 
  
  
 GEN111R048 
 missense_variant 
 c.52G>A 
 p.Val18Ile 
 Unknown 
  
  
 GEN111R049 
 missense_variant 
 c.1768G>A 
 p.Ala590Thr 
 Unknown 
  
  
 GEN111R050 
 missense_variant 
 c.3118G>A 
 p.Gly1040Ser 
 Unknown 
  
  
 GEN111R051 
 missense_variant 
 c.3296G>A 
 p.Arg1099His 
 Unknown 
  
  
 GEN111R052 
 missense_variant 
 c.3875A>G 
 p.Lys1292Arg 
 Unknown 
  
  
 GEN111R053 
 stop_gained 
 c.1555C>T 
 p.Arg519Ter 
 De novo 
  
  
 GEN111R054 
 missense_variant 
 c.2087G>A 
 p.Arg696His 
 De novo 
  
 Extended multiplex 
 GEN111R055 
 missense_variant 
 c.1306T>C 
 p.Cys436Arg 
 De novo 
  
  
 GEN111R056 
 stop_gained 
 c.737C>A 
 p.Ser246Ter 
 De novo 
  
 Simplex 
 GEN111R057 
 missense_variant 
 c.2252T>C 
 p.Ile751Thr 
 De novo 
  
  
 GEN111R058 
 inversion 
  
  
 De novo 
  
  
 GEN111R059 
 translocation 
  
  
 De novo 
  
  
 GEN111R060 
 missense_variant 
 c.1460G>C 
 p.Gly487Ala 
 De novo 
  
  
 GEN111R061 
 frameshift_variant 
 c.2384_2391del 
 p.Leu795HisfsTer7 
 De novo 
  
  
 GEN111R062 
 frameshift_variant 
 c.91_92insC 
 p.Ser31ThrfsTer28 
 De novo 
  
  
 GEN111R063 
 missense_variant 
 c.1376G>A 
 p.Gly459Glu 
 De novo 
  
  
 GEN111R064 
 missense_variant 
 c.4270C>T 
 p.Leu1424Phe 
 Unknown 
  
  
 GEN111R065 
 missense_variant 
 c.4355C>T 
 p.Ser1452Phe 
 Unknown 
  
  
 GEN111R066 
 missense_variant 
 c.2116A>G 
 p.Met706Val 
 De novo 
  
  
 GEN111R067 
 missense_variant 
 c.448A>G 
 p.Ile150Val 
 De novo 
  
  
 GEN111R068 
 missense_variant 
 c.1306T>C 
 p.Cys436Arg 
 De novo 
  
  
 GEN111R069 
 missense_variant 
 c.1495G>A 
 p.Gly499Arg 
 De novo 
  
  
 GEN111R070 
 missense_variant 
 c.1540A>G 
 p.Thr514Ala 
 De novo 
  
  
 GEN111R071 
 missense_variant 
 c.1547A>G 
 p.Asn516Ser 
 De novo 
  
  
 GEN111R072 
 missense_variant 
 c.1619G>A 
 p.Arg540His 
 De novo 
  
  
 GEN111R073 
 missense_variant 
 c.1623C>G 
 p.Ser541Arg 
 De novo 
  
  
 GEN111R074 
 missense_variant 
 c.1664G>T 
 p.Ser555Ile 
 De novo 
  
  
 GEN111R075 
 missense_variant 
 c.1672G>A 
 p.Val558Ile 
 De novo 
  
  
 GEN111R076 
 missense_variant 
 c.1832G>T 
 p.Gly611Val 
 De novo 
  
  
 GEN111R077 
 missense_variant 
 c.1848C>G 
 p.Asn616Lys 
 De novo 
  
  
 GEN111R078 
 missense_variant 
 c.1883C>G 
 p.Ser628Cys 
 De novo 
  
  
 GEN111R079 
 missense_variant 
 c.1907C>T 
 p.Ala636Val 
 De novo 
  
  
 GEN111R080 
 missense_variant 
 c.1916C>T 
 p.Ala639Val 
 De novo 
  
  
 GEN111R081 
 missense_variant 
 c.1963A>T 
 p.Ile655Phe 
 De novo 
  
  
 GEN111R082 
 missense_variant 
 c.1970A>G 
 p.Glu657Gly 
 De novo 
  
  
 GEN111R083 
 missense_variant 
 c.2002G>T 
 p.Asp668Tyr 
 De novo 
  
  
 GEN111R084 
 missense_variant 
 c.2065G>A 
 p.Gly689Ser 
 De novo 
  
  
 GEN111R085 
 missense_variant 
 c.2065G>A 
 p.Gly689Ser 
 De novo 
  
  
 GEN111R086 
 missense_variant 
 c.2079A>T 
 p.Arg693Ser 
 De novo 
  
  
 GEN111R087 
 missense_variant 
 c.2084T>C 
 p.Ile695Thr 
 De novo 
  
  
 GEN111R088 
 missense_variant 
 c.2087G>A 
 p.Arg696His 
 De novo 
  
  
 GEN111R089 
 missense_variant 
 c.2087G>A 
 p.Arg696His 
 De novo 
  
  
 GEN111R090 
 missense_variant 
 c.2116A>G 
 p.Met706Val 
 De novo 
  
  
 GEN111R091 
 missense_variant 
 c.2201C>T 
 p.Ala734Val 
 De novo 
  
  
 GEN111R092 
 missense_variant 
 c.2252T>C 
 p.Ile751Thr 
 De novo 
  
  
 GEN111R093 
 missense_variant 
 c.2252T>C 
 p.Ile751Thr 
 De novo 
  
  
 GEN111R094 
 missense_variant 
 c.2252T>C 
 p.Ile751Thr 
 De novo 
  
  
 GEN111R095 
 missense_variant 
 c.2430C>A 
 p.Ser810Arg 
 De novo 
  
  
 GEN111R096 
 missense_variant 
 c.2429G>A 
 p.Ser810Asn 
 De novo 
  
  
 GEN111R097 
 missense_variant 
 c.2452A>C 
 p.Met818Leu 
 De novo 
  
  
 GEN111R098 
 missense_variant 
 c.2453T>C 
 p.Met818Thr 
 De novo 
  
  
 GEN111R099 
 missense_variant 
 c.2455G>A 
 p.Ala819Thr 
 De novo 
  
  
 GEN111R100 
 missense_variant 
 c.2459G>C 
 p.Gly820Ala 
 De novo 
  
  
 GEN111R101 
 missense_variant 
 c.2459G>C 
 p.Gly820Ala 
 De novo 
  
  
 GEN111R102 
 missense_variant 
 c.2459G>C 
 p.Gly820Ala 
 De novo 
  
  
 GEN111R103 
 missense_variant 
 c.2459G>C 
 p.Gly820Ala 
 De novo 
  
  
 GEN111R104 
 missense_variant 
 c.2459G>T 
 p.Gly820Val 
 De novo 
  
  
 GEN111R105 
 missense_variant 
 c.2477G>A 
 p.Gly826Glu 
 De novo 
  
  
 GEN111R106 
 inframe_deletion 
 c.2926_2928del 
 p.Lys976del 
 De novo 
  
  
 GEN111R107 
 missense_variant 
 c.3332G>A 
 p.Arg1111His 
 De novo 
  
  
 GEN111R108 
 stop_gained 
 c.538C>T 
 p.Gln180Ter 
 De novo 
  
  
 GEN111R109 
 stop_gained 
 c.737C>A 
 p.Ser246Ter 
 De novo 
  
  
 GEN111R110 
 stop_gained 
 c.1119G>A 
 p.Trp373Ter 
 De novo 
  
  
 GEN111R111 
 stop_gained 
 c.1966C>T 
 p.Gln656Ter 
 De novo 
  
  
 GEN111R112 
 stop_gained 
 c.2539C>T 
 p.Arg847Ter 
 De novo 
  
  
 GEN111R113 
 stop_gained 
 c.2539C>T 
 p.Arg847Ter 
 De novo 
  
  
 GEN111R114 
 stop_gained 
 c.3012C>G 
 p.Tyr1004Ter 
 De novo 
  
  
 GEN111R115 
 missense_variant 
 c.1573T>G 
 p.Phe525Val 
 De novo 
  
 Simplex 
 GEN111R117 
 missense_variant 
 c.2459G>A 
 p.Gly820Glu 
 De novo 
  
 Simplex 
 GEN111R118 
 missense_variant 
 c.1768G>A 
 p.Ala590Thr 
 Familial 
  
  
 GEN111R119 
 missense_variant 
 c.3799G>T 
 p.Ala1267Ser 
 Familial 
 Paternal 
  
 GEN111R120 
 missense_variant 
 c.3993G>A 
 p.Met1331Ile 
 Unknown 
  
  
 GEN111R121 
 missense_variant 
 c.4307G>C 
 p.Gly1436Ala 
 Familial 
 Paternal 
 Multiplex 
 GEN111R122 
 missense_variant 
 c.2053A>C 
 p.Thr685Pro 
 De novo 
  
  
 GEN111R123 
 missense_variant 
 c.2087G>A 
 p.Arg696His 
 De novo 
  
 Simplex 
 GEN111R124 
 stop_gained 
 c.2607C>G 
 p.Tyr869Ter 
 De novo 
  
 Simplex 
 GEN111R125 
 missense_variant 
 c.2395G>A 
 p.Gly799Ser 
 De novo 
  
  
 GEN111R126 
 missense_variant 
 c.1238A>G 
 p.Glu413Gly 
 De novo 
  
  
 GEN111R127 
 missense_variant 
 c.1928T>C 
 p.Leu643Pro 
 De novo 
  
  
 GEN111R128 
 missense_variant 
 c.2461G>C 
 p.Val821Leu 
 Unknown 
  
  
 GEN111R129 
 missense_variant 
 c.2087G>A 
 p.Arg696His 
 De novo 
  
  
 GEN111R130 
 missense_variant 
 c.1921A>C 
 p.Ile641Leu 
 De novo 
  
  
 GEN111R131 
 missense_variant 
 c.2087G>A 
 p.Arg696His 
 De novo 
  
 Simplex 
 GEN111R132 
 missense_variant 
 c.2084T>C 
 p.Ile695Thr 
 De novo 
  
 Simplex 
 GEN111R133 
 synonymous_variant 
 c.2731C>T 
 p.Leu911= 
 De novo 
  
  
 GEN111R134 
 stop_gained 
 c.1555C>T 
 p.Arg519Ter 
 De novo 
  
 Simplex 
 GEN111R135 
 frameshift_variant 
 c.23_24insC 
 p.Ser9PhefsTer50 
 De novo 
  
 Simplex 
 GEN111R136 
 frameshift_variant 
 c.2208dup 
 p.Asn737GlufsTer8 
 De novo 
  
 Simplex 
 GEN111R137 
 missense_variant 
 c.3895C>T 
 p.Arg1299Cys 
 De novo 
  
  
 GEN111R138 
 missense_variant 
 c.2791G>A 
 p.Val931Ile 
 De novo 
  
  
 GEN111R139 
 missense_variant 
 c.2056G>A 
 p.Val686Met 
 De novo 
  
  
 GEN111R140 
 splice_site_variant 
 c.2010+1G>C 
  
 De novo 
  
  
 GEN111R141 
 missense_variant 
 c.2002G>A 
 p.Asp668Asn 
 De novo 
  
  
 GEN111R142 
 stop_gained 
 c.1437C>A 
 p.Tyr479Ter 
 De novo 
  
  
 GEN111R143 
 frameshift_variant 
 c.2394_2395insTGGCATTTGTCACAATG 
 p.Gly799TrpfsTer17 
 Unknown 
  
  
 GEN111R144 
 stop_gained 
 c.3437G>A 
 p.Trp1146Ter 
 Unknown 
  
  
 GEN111R145 
 frameshift_variant 
 c.2394_2395insTGGCATTTGTCACAATG 
 p.Gly799TrpfsTer17 
 Unknown 
  
  
 GEN111R146 
 splice_site_variant 
 c.1780+1G>A 
  
 Unknown 
  
  
 GEN111R147 
 splice_site_variant 
 c.1010+1G>A 
  
 Unknown 
  
  
 GEN111R148 
 frameshift_variant 
 c.2862_2863del 
 p.Cys954Ter 
 Unknown 
  
  
 GEN111R149 
 missense_variant 
 c.2060C>T 
 p.Pro687Leu 
 De novo 
  
  
 GEN111R150 
 missense_variant 
 c.2087G>A 
 p.Arg696His 
 De novo 
  
  
 GEN111R151 
 missense_variant 
 c.2087G>A 
 p.Arg696His 
 Unknown 
  
  
 GEN111R152 
 missense_variant 
 c.286G>T 
 p.Gly96Trp 
 Unknown 
  
  
 GEN111R153 
 missense_variant 
 c.286G>T 
 p.Gly96Trp 
 Unknown 
  
  
 GEN111R154 
 missense_variant 
 c.2002G>T 
 p.Asp668Tyr 
 Unknown 
  
  
 GEN111R155 
 missense_variant 
 c.1619G>A 
 p.Arg540His 
 Unknown 
  
  
 GEN111R156 
 missense_variant 
 c.1367G>A 
 p.Cys456Tyr 
 Unknown 
  
  
 GEN111R157 
 missense_variant 
 c.1037G>A 
 p.Gly346Glu 
 Unknown 
  
  
 GEN111R158 
 missense_variant 
 c.1570G>A 
 p.Asp524Asn 
 Unknown 
  
  
 GEN111R159 
 frameshift_variant 
 c.99dup 
 p.Ser34GlnfsTer25 
 Unknown 
  
  
 GEN111R160 
 stop_gained 
 c.2539C>T 
 p.Arg847Ter 
 Unknown 
  
  
 GEN111R161 
 stop_gained 
 c.2539C>T 
 p.Arg847Ter 
 Unknown 
  
  
 GEN111R162 
 frameshift_variant 
 c.3937_3940del 
 p.Glu1313LysfsTer9 
 Unknown 
  
  
 GEN111R163 
 frameshift_variant 
 c.996del 
 p.Asn333IlefsTer3 
 Unknown 
  
  
 GEN111R164 
 stop_gained 
 c.258T>A 
 p.Cys86Ter 
 Unknown 
  
  
 GEN111R165 
 missense_variant 
 c.2087G>A 
 p.Arg696His 
 Unknown 
  
  
 GEN111R166 
 missense_variant 
 c.3722G>A 
 p.Arg1241Gln 
 Unknown 
  
  
 GEN111R167 
 missense_variant 
 c.2086C>A 
 p.Arg696Ser 
 Unknown 
  
  
 GEN111R168 
 missense_variant 
 c.2044C>T 
 p.Arg682Cys 
 Unknown 
  
  
 GEN111R169 
 missense_variant 
 c.2198C>T 
 p.Ala733Val 
 De novo 
  
  
 GEN111R170 
 missense_variant 
 c.1556G>A 
 p.Arg519Gln 
 Unknown 
  
  
 GEN111R171 
 missense_variant 
 c.2644T>G 
 p.Ser882Ala 
 De novo 
  
  
 GEN111R172 
 missense_variant 
 c.1849T>A 
 p.Ser617Thr 
 De novo 
  
 Simplex 
 GEN111R173 
 missense_variant 
 c.1619G>A 
 p.Arg540His 
 Unknown 
  
  
 GEN111R174 
 missense_variant 
 c.2065G>A 
 p.Gly689Ser 
 De novo 
  
  
 GEN111R175 
 missense_variant 
 c.1928T>C 
 p.Leu643Pro 
 De novo 
  
 Simplex 
 GEN111R176 
 frameshift_variant 
 c.2590_2593dup 
 p.Ser865AsnfsTer47 
 Unknown 
  
  
 GEN111R177 
 frameshift_variant 
 c.2409_2419dup 
 p.Glu807ValfsTer7 
 Unknown 
  
  
 GEN111R178 
 missense_variant 
 c.2087G>A 
 p.Arg696His 
 Unknown 
  
  
 GEN111R179 
 missense_variant 
 c.2044C>T 
 p.Arg682Cys 
 Unknown 
  
  
 GEN111R180 
 missense_variant 
 c.1619G>A 
 p.Arg540His 
 Unknown 
  
  
 GEN111R181 
 stop_gained 
 c.1136G>A 
 p.Trp379Ter 
 Unknown 
  
  
 GEN111R182 
 frameshift_variant 
 c.1711del 
 p.Ala571ProfsTer80 
 De novo 
  
  
 GEN111R183 
 missense_variant 
 c.2498T>C 
 p.Leu833Pro 
 Unknown 
  
  
 GEN111R184 
 stop_gained 
 c.2539C>T 
 p.Arg847Ter 
 De novo 
  
  
 GEN111R185 
 missense_variant 
 c.2065G>A 
 p.Gly689Ser 
 De novo 
  
 Simplex 
 GEN111R186 
 missense_variant 
 c.2437C>G 
 p.Leu813Val 
 De novo 
  
 Simplex 
 GEN111R187 
 missense_variant 
 c.2438T>C 
 p.Leu813Pro 
 De novo 
  
 Simplex 
 GEN111R188 
 missense_variant 
 c.2453T>C 
 p.Met818Thr 
 De novo 
  
 Simplex 
 GEN111R189 
 missense_variant 
 c.2515G>A 
 p.Glu839Lys 
 De novo 
  
  
 GEN111R190 
 missense_variant 
 c.2459G>C 
 p.Gly820Ala 
 De novo 
  
  
 GEN111R191 
 synonymous_variant 
 c.4410T>C 
 p.Asn1470%3D 
 De novo 
  
 Simplex 
 GEN111R192 
 missense_variant 
 c.2515G>A 
 p.Glu839Lys 
 De novo 
  
 Simplex 
 GEN111R193 
 inframe_deletion 
 c.804_824del 
 p.Val269_Thr275del 
 De novo 
  
  
 GEN111R194 
 missense_variant 
 c.3766G>A 
 p.Glu1256Lys 
 De novo 
  
  
 GEN111R195 
 missense_variant 
 c.2377G>A 
 p.Glu793Lys 
 De novo 
  
  
 GEN111R196 
 missense_variant 
 c.2087G>A 
 p.Arg696His 
 De novo 
  
  
 GEN111R197 
 missense_variant 
 c.1837G>A 
 p.Val613Met 
 De novo 
  
  
 GEN111R198 
 missense_variant 
 c.1556G>A 
 p.Arg519Gln 
 De novo 
  
  
 GEN111R199 
 stop_gained 
 c.538C>T 
 p.Gln180Ter 
 De novo 
  
  
 GEN111R200 
 stop_gained 
 c.3931C>T 
 p.Gln1311Ter 
 Unknown 
  
  
 GEN111R201 
 missense_variant 
 c.1661T>G 
 p.Phe554Cys 
 De novo 
  
 Simplex 
 GEN111R202 
 frameshift_variant 
 c.2825del 
 p.Thr942SerfsTer25 
 De novo 
  
  
 GEN111R203 
 frameshift_variant 
 c.2555del 
 p.Gly852ValfsTer32 
 De novo 
  
  
 GEN111R204 
 copy_number_loss 
  
  
 De novo 
  
  
 GEN111R205 
 missense_variant 
 c.1427A>G 
 p.Tyr476Cys 
 De novo 
  
  
 GEN111R206 
 missense_variant 
 c.1460G>C 
 p.Gly487Ala 
 De novo 
  
 Multiplex 
 GEN111R207 
 translocation 
  
  
 De novo 
  
 Simplex 
 GEN111R208 
 missense_variant 
 c.3680C>T 
 p.Thr1227Met 
 Unknown 
  
 Simplex 
 GEN111R209 
 missense_variant 
 c.1246T>C 
 p.Phe416Leu 
 De novo 
  
 Simplex 
  et al.  
 GEN111R210 
 stop_gained 
 c.3912C>G 
 p.Tyr1304Ter 
 De novo 
  
  
  et al.  
 GEN111R211 
 stop_gained 
 c.1555C>T 
 p.Arg519Ter 
 Unknown 
  
  
  et al.  

Common

Variant ID
Polymorphism
SNP ID
Allele Change
Residue Change
Population Origin
Population Stage
Author, Year
 GEN111C001 
 3_prime_UTR_variant 
  
 T5072G 
 N/A 
 Canadian 
 Discovery 
 GEN111C002 
 3_prime_UTR_variant 
  
 T5988C 
 N/A 
 Canadian 
 Discovery 
 GEN111C003 
 synonymous_variant 
 rs34315573 
 c.15G>T 
 p.(=) 
 Japanese 
 Discovery 
 GEN111C004 
 synonymous_variant 
 rs7301328 
 c.366C>G 
 p.(=) 
 Japanese 
 Discovery 
 GEN111C005 
 synonymous_variant 
 rs1805482 
 c.1665C>T 
 p.(=) 
 Japanese 
 Discovery 
 GEN111C006 
 synonymous_variant 
 rs1806201 
 c.2664C>T 
 p.(=) 
 Japanese 
 Discovery 
 GEN111C007 
 synonymous_variant 
 rs1805247 
 c.4197T>C 
 p.(=) 
 Japanese 
 Discovery 
 GEN111C008 
 3_prime_UTR_variant 
  
 C4615T 
  
 Japanese 
 Discovery 
 GEN111C009 
 3_prime_UTR_variant 
  
 A5806A/C 
  
 Japanese 
 Discovery 
 GEN111C010 
 3_prime_UTR_variant 
  
 5988T/C 
  
 Japanese 
 Discovery 
 GEN111C011 
 intron_variant 
 rs918168 
 c.-19+54228G>A 
 A/G 
 67 ASD patients and 117 healthy controls 
 Discovery 
 GEN111C012 
 downstream_gene_variant 
 rs7961819 
  
 G/A 
 Meta-analysis of 275 case-parent triad families (n=825) and case-cohort cohort (n=1,120) of Chinese descent 
 Discovery 
 GEN111C013 
 intron_variant 
 rs7970177 
 c.2011-14090A>G;c.-43-16037A>G 
 A/G 
 Meta-analysis of 275 case-parent triad families (n=825) and case-cohort cohort (n=1,120) of Chinese descent 
 Discovery 
 GEN111C014 
 intron_variant 
 rs1805474 
 c.2011-17252A>C;c.-43-19199A>C 
  
 Meta-analysis of 275 case-parent triad families (n=825) and case-cohort cohort (n=1,120) of Chinese descent 
 Discovery 
 GEN111C015 
 intron_variant 
 rs888150 
 c.2010+16493A>G;c.-44+16493A>G 
 A/G 
 Meta-analysis of 275 case-parent triad families (n=825) and case-cohort cohort (n=1,120) of Chinese descent 
 Discovery 
 GEN111C016 
 intron_variant 
 rs1805510 
 c.2010+10285C>A;c.-44+10285C>A 
 A/C 
 Meta-analysis of 275 case-parent triad families (n=825) and case-cohort cohort (n=1,120) of Chinese descent 
 Discovery 
 GEN111C017 
 intron_variant 
 rs2268097 
 c.2010+8705T>C;c.-44+8705T>C 
 A/G 
 Meta-analysis of 275 case-parent triad families (n=825) and case-cohort cohort (n=1,120) of Chinese descent 
 Discovery 
 GEN111C018 
 intron_variant 
 rs2300238 
 c.1125+15349G>A 
 A/G 
 Meta-analysis of 275 case-parent triad families (n=825) and case-cohort cohort (n=1,120) of Chinese descent 
 Discovery 
 GEN111C019 
 intron_variant 
 rs980365 
 c.1125+8652A>G 
 A/G 
 Meta-analysis of 275 case-parent triad families (n=825) and case-cohort cohort (n=1,120) of Chinese descent 
 Discovery 
 GEN111C020 
 intron_variant 
 rs2268102 
 c.1125+6440G>A 
 A/G 
 Meta-analysis of 275 case-parent triad families (n=825) and case-cohort cohort (n=1,120) of Chinese descent 
 Discovery 
 GEN111C021 
 intron_variant 
 rs2284406 
 c.1125+3263A>G 
 A/G 
 Meta-analysis of 275 case-parent triad families (n=825) and case-cohort cohort (n=1,120) of Chinese descent 
 Discovery 
 GEN111C022 
 intron_variant 
 rs1008619 
 c.1125+2272T>C 
  
 Meta-analysis of 275 case-parent triad families (n=825) and case-cohort cohort (n=1,120) of Chinese descent 
 Discovery 
 GEN111C023 
 intron_variant 
 rs918065 
 c.1011-13916G>A 
 A/G 
 Meta-analysis of 275 case-parent triad families (n=825) and case-cohort cohort (n=1,120) of Chinese descent 
 Discovery 
 GEN111C024 
 intron_variant 
 rs2216128 
 c.1010+23237C>T 
 G/A 
 Meta-analysis of 275 case-parent triad families (n=825) and case-cohort cohort (n=1,120) of Chinese descent 
 Discovery 
 GEN111C025 
 intron_variant 
 rs2192973 
 c.1010+9696T>C 
 A/G 
 Meta-analysis of 275 case-parent triad families (n=825) and case-cohort cohort (n=1,120) of Chinese descent 
 Discovery 
 GEN111C026 
 intron_variant 
 rs2300266 
 c.412-44918A>C 
 C/A 
 Meta-analysis of 275 case-parent triad families (n=825) and case-cohort cohort (n=1,120) of Chinese descent 
 Discovery 
 GEN111C027 
 intron_variant 
 rs11055625 
 c.412-46045T>C 
 G/A 
 Meta-analysis of 275 case-parent triad families (n=825) and case-cohort cohort (n=1,120) of Chinese descent 
 Discovery 
 GEN111C028 
 intron_variant 
 rs2160732 
 c.411+37406T>G 
 C/A 
 Meta-analysis of 275 case-parent triad families (n=825) and case-cohort cohort (n=1,120) of Chinese descent 
 Discovery 
 GEN111C029 
 intron_variant 
 rs1861787 
 c.411+18164C>A 
 A/C 
 Meta-analysis of 275 case-parent triad families (n=825) and case-cohort cohort (n=1,120) of Chinese descent 
 Discovery 
 GEN111C030 
 intron_variant 
 rs2284428 
 c.411+8818T>C 
 G/A 
 Meta-analysis of 275 case-parent triad families (n=825) and case-cohort cohort (n=1,120) of Chinese descent 
 Discovery 
 GEN111C031 
 synonymous_variant 
 rs1805247 
 c.4197T>C;c.1983T>C 
 p.(=) 
 275 Chinese ASD cases from triad families and Asian samples from the 1000 Genomes project as controls 
 Discovery 
 GEN111C032 
 synonymous_variant 
 rs1805522 
 c.1806C>T;c.-248C>T 
 p.(=) 
 275 Chinese ASD cases from triad families and Asian samples from the 1000 Genomes project as controls 
 Discovery 
Chromosome
CNV Locus
CNV Type
# of studies
Animal Model
12
Deletion
 11
 
12
Deletion
 1
 
12
Deletion
 2
 
12
Deletion
 4
 
12
Duplication
 5
 
12
Deletion
 1
 
12
Duplication
 2
 
12
Duplication
 1
 
12
Duplication
 1
 

Model Summary

Changes in learning, especially flexibility or reversal learning are seen in mouse models that have conditional deletions in Grin2b ( knocked out post natally in specific parts of the forebrain).

References

Type
Title
Author, Year
Additional
Genetic enhancement of learning and memory in mice.
Additional
Contribution of hippocampal and extra-hippocampal NR2B-containing NMDA receptors to performance on spatial learning tasks.
Primary
Loss of GluN2B-containing NMDA receptors in CA1 hippocampus and cortex impairs long-term depression, reduces dendritic spine density, and disrupts ...
Additional
A critical role for GluN2B-containing NMDA receptors in cortical development and function.
Primary
GluN2B in corticostriatal circuits governs choice learning and choice shifting.
Additional
Impairment of suckling response, trigeminal neuronal pattern formation, and hippocampal LTD in NMDA receptor epsilon 2 subunit mutant mice

M_GRIN2B_4_TG

Model Type: Genetic
Model Genotype: Heterozygous
Mutation: Grin2B transgenic mouse, named Doogie, over-express the Grin2B (NR2B) subunit postnatally in the forebrain under the CaM-kinase-II promoter. Two independently generated transgenic lines were used.
Allele Type: Transgenic
Strain of Origin: C57B/6
Genetic Background: C57B/6 *B6/CBF1
ES Cell Line:
Mutant ES Cell Line:
Model Source:

M_GRIN2B_5_CKO_HM

Model Type: Genetic
Model Genotype: Homozygous
Mutation: Conditional deletion of exon9 of the Grin2B gene using CamkII-cre promoter region from Cre4, which is activated postnally,in forebrain principal neurons of hippocampus, striatum, thalamus, amygdala, cortex, and olfactory bulb
Allele Type: Conditional loss-of-function
Strain of Origin: Unreported
Genetic Background: Unreported
ES Cell Line:
Mutant ES Cell Line:
Model Source:

M_GRIN2B_6_CKO_HM

Model Type: Genetic
Model Genotype: Homozygous
Mutation: Conditional deletion of exon 9 of the Grin2b gene using CamkII-cre in the background of double transgenes CN12-itTA and LC1-cre, pregrant females were treated with doxycycline to keep the cre recombinase under the LC1 transgene silenced, postnatally the pups were transferred to an untreated foster mother leading to activation of the cre recombinase in dorsal region of CA1 and the entire dentate gyrus of the hippocampus
Allele Type: Conditional loss-of-function
Strain of Origin: Unreported
Genetic Background: CN12-itTA/LC1
ES Cell Line:
Mutant ES Cell Line:
Model Source:

M_GRIN2B_1_CKO_HM

Model Type: Genetic
Model Genotype: Homozygous
Mutation: Conditional deletion of exon 2 (or 5, depending on the alternative transcripts) of the GluN2B or Grin2B using CamkII-Cre recombinase containing transgenic mice. Postnatal activation of Cre produces nullizygous Grin2B mice with no Glun2B in the cortex and hippocampal CA1 region.
Allele Type: Conditional loss-of-function
Strain of Origin: 129/SvEvTac
Genetic Background: 129S6/SvEvTac * BALB/c * C57BL/6 (95% C57BL/6)
ES Cell Line:
Mutant ES Cell Line:
Model Source:

M_GRIN2B_10_TG_HT_GRIN2A

Model Type: Genetic
Model Genotype: Heterozygous
Mutation: The first coding exon of Grin2B was replaced with a targeted construct including the full-length cDNA encoding the rat Grin2A subunit that lacked the translation start codon of GluN2B and included a pgk-Neomycin resistance cassette used for in vitro selection. The resultingGrin-2B/2A inserted allele replaced the Grin2B gene with Grin2A.
Allele Type: Targeted; Transgenic
Strain of Origin:
Genetic Background:
ES Cell Line:
Mutant ES Cell Line:
Model Source:

M_GRIN2B_7_TG_HM_GRIN2A

Model Type: Genetic
Model Genotype: Homozygous
Mutation: The first coding exon of Grin2B was replaced with a targeted construct including the full-length cDNA encoding the rat Grin2A subunit that lacked the translation start codon of GluN2B and included a pgk-Neomycin resistance cassette used for in vitro selection. The resultingGrin-2B/2A inserted allele replaced the Grin2B gene with Grin2A.
Allele Type: Targeted; Transgenic
Strain of Origin:
Genetic Background:
ES Cell Line:
Mutant ES Cell Line:
Model Source:

M_GRIN2B_8_KO_HM

Model Type: Genetic
Model Genotype: Homozygous
Mutation: Homozygous Grin2B knockout mice were generated (as previously reported in PMID 8789948) by homologous recombination with the construct pTVGRe2 containing a neomycin selection cassette.
Allele Type: Targeted
Strain of Origin: C57BL/6
Genetic Background: C57BL/6
ES Cell Line:
Mutant ES Cell Line: TT2 embryonic stem cells
Model Source:

M_GRIN2B_9_CKO_HM

Model Type: Genetic
Model Genotype: Homozygous
Mutation: Conditional deletion of exon 3 (or 5 depending on the alternative transcript) of the Grin2B gene using Nex-Cre, in neurons and glia of the neocortex, hippocampus and pallium, E10.5 onwards
Allele Type: Conditional loss-of-function
Strain of Origin: C57BL/6J
Genetic Background: C57BL/6J
ES Cell Line:
Mutant ES Cell Line:
Model Source:

M_GRIN2B_2_CKO_HM

Model Type: Genetic
Model Genotype: Homozygous
Mutation: Conditional deletion of exon 2 (or 5, depending on the alternative transcripts) of the GluN2B or Grin2B using Rgs9-cre, in the striatal neurons postnatally
Allele Type: Conditional loss-of-function
Strain of Origin: 129/SvEvTac
Genetic Background: 129S6/SvEvTac * BALB/c * C57BL/6
ES Cell Line:
Mutant ES Cell Line:
Model Source:

M_GRIN2B_3_WT_ANT

Model Type: Genetic
Model Genotype: Wild type
Mutation: The antagonist Ro 25-6981 is a selective inhibitor of the Grin2B gene product- GluN2B, one of the modulatory subunits for NMDA receptors in the brain.It was infused into the dorsal straitum in wild type mice during behavioral testing.
Allele Type:
Strain of Origin:
Genetic Background: C57BL/6
ES Cell Line:
Mutant ES Cell Line:
Model Source:

M_GRIN2B_8_KO_HT

Model Type: Genetic
Model Genotype: Heterozygous
Mutation: Homozygous Grin2B knockout mice were generated (as previously reported in PMID 8789948) by homologous recombination with the construct pTVGRe2 containing a neomycin selection cassette.
Allele Type: Targeted
Strain of Origin: C57BL/6
Genetic Background: C57BL/6
ES Cell Line:
Mutant ES Cell Line: TT2 embryonic stem cells
Model Source:

M_GRIN2B_4_TG

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Synaptic plasticity: hippocampal ltp1
Increased
Description: Transgenics show larger potentiation with the same stimulus than control animals. in the first 10mins after tetanic stimulation transgenics showed no decay compared to the fast decay in control animals. similar results were obtained with prolonged, repetitive stimulation. stimulation at 10-hz for 1.5min (900 pulses) evoked robust synaptic potentiation in transgenic slices but no potentiation in controls.
Exp Paradigm: Synaptic plasticity with 1 to 100hz stimulation and prolonged repetitive stimulation, was measured.
 Field potential recordings
 4-6 months
Local field potential: nmda mediated local field epsps1
Increased
Description: Nmda-receptor-mediated field epsps in transgenic mice were greater than those in wild-type mice.
Exp Paradigm: Nmda receptor-mediated epsps were isolated in the presence of 10 mm cnqx and 0.1 mm mg ion. nmda specificity was demonstrated by nmda-receptor antagonist d(-)-amino-7-phosphonovaleric acid.
 In vivo local field potential (lfp) recordings
 4-6 months
Cued or contextual fear conditioning: memory of cue1
Increased
Description: Transgenics show increased freezing in response to the tone at 1hr, 1 day and 10 days, compared to controls.
Exp Paradigm: The conditioned stimulus used was an 85db sound at 2,800 hz, and the unconditioned stimulus was a continuous scrambled foot shock at 0.75 ma.
 Fear conditioning test
 3-6 months
Spatial reference memory1
Increased
Description: Transgenics show a clear preference for the quadrant where the platform was previously located compared to control animals.
Exp Paradigm: Time spent in the quadrant where the platform was earlier located was measured.
 Morris water maze test
 3-6 months
Cued or contextual fear conditioning: memory of context1
Increased
Description: Transgenics show increased freezing in response to the shock chamber at 1hr, 1 day and 10 days post training, compared to controls.
Exp Paradigm: The conditioned stimulus used was an 85db sound at 2,800 hz, and the unconditioned stimulus was a continuous scrambled foot shock at 0.75 ma. contextual memory was measured by freezing responses on placing the animal in the shock chamber for three minutes.
 Fear conditioning test
 3-6 months
Spatial learning1
Increased
Description: Transgenics show decreased latency to escape to the platform compared to control mice.
Exp Paradigm: Latency to reach the hidden platform was measured.
 Morris water maze test
 3-6 months
Cued or contextual fear conditioning: extinction1
Increased
Description: Transgenics show quicker dissociation of the previously learned conditional pairing in cued and contextual pairing, than control animals.
Exp Paradigm: The extinction was measured over 5 trials at 1 - 24 hours post training.
 Fear conditioning test
 3-6 months
Object recognition memory1
Increased
Description: Transgenics show increased retention of the memory of a novel object than control animals at 1 and 3 days post training but no change at 1 hour post training.
Exp Paradigm: Memory retention was measured 1 and 3 days post training. during the retention phase of the novel object recognition test one of the familiar objects used in the training session was replaced with a third novel object, and animals were allowed to explore for 5 min.
 Novel object recognition test
 3-6 months
Protein expression level evidence1
Increased
Description: Transgenics show increased expression of grin1 gene product (nr1 protein) compared to controls.
Exp Paradigm: NA
 Western blot
 Not specified
Targeted expression1
Increased
Description: Transgenics show increased expression of grin2b transgene protein product in the cortex and hippocampus with no increase of expression in the thalamus, brainstem and cerebellum, compared to controls. transgenics show increased gene expression of grin2b transgene in the cortex, striatum, hippocampus and amygdala compared to controls.
Exp Paradigm: Western blot
 Western blot
 P14
Targeted expression1
Increased
Description: Transgenics show increased expression of grin2b transgene protein product in the cortex and hippocampus with no increase of expression in the thalamus, brainstem and cerebellum, compared to controls. transgenics show increased gene expression of grin2b transgene in the cortex, striatum, hippocampus and amygdala compared to controls.
Exp Paradigm: Northern blot
 Northern blot
 P14
Targeted expression1
Increased
Description: Transgenics show increased expression of grin2b transgene protein product in the cortex and hippocampus with no increase of expression in the thalamus, brainstem and cerebellum, compared to controls. transgenics show increased gene expression of grin2b transgene in the cortex, striatum, hippocampus and amygdala compared to controls.
Exp Paradigm: In situ hybridization (ish)
 In situ hybridization (ish)
 P14
Size/growth1
 No change
 Body weight measurement
 Not specified
Exploratory activity1
 No change
 Novel object recognition test
 3-6 months
Object recognition memory: long-term recall1
 No change
 Novel object recognition test
 3-6 months
Protein expression level evidence1
 No change
 Western blot
 Not specified
Brain morphology1
 No change
 Histology
 Not specified
Dendritic architecture: spine density1
 No change
 Histology
 Not specified
Hippocampal morphology1
 No change
 Histology
 Not specified
Local field potential: ampa mediated local field epsps1
 No change
 In vivo local field potential (lfp) recordings
 4-6 months
Presynaptic function: paired-pulse facilitation1
 No change
 Paired-pulse ratio
 4-6 months
Synaptic plasticity: hippocampal ltd1
 No change
 Field potential recordings
 4-6 months
Seizures1
 No change
 Observation of seizures
 Not specified
Pain or nociception1
 No change
 Foot shock test
 3-6 months
 Not Reported: Circadian sleep/wake cycle, Communications, Immune response, Maternal behavior, Motor phenotype, Physiological parameters, Repetitive behavior, Social behavior

M_GRIN2B_5_CKO_HM

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Spontaneous movement1
Increased
Description: Mutants show increased activity compared to controls.
Exp Paradigm: NA
 Spontaneous movement analysis
 5 months
Decay kinetics of miniature post synaptic currents1
Decreased
Description: Mutants show decrease in mepsc amplitude 50ms after the onset of mepscs compared to controls.
Exp Paradigm: Nmdar mediated component of mepsps was measured 50ms after mepsp onset recorded in a mg ion free solution.
 Whole-cell patch clamp
 6-7 weeks
Synaptic neuroreceptor ratio (nmdar/ampar) dependent transmission1
Increased
Description: Mutants show increased ampa/nmda epsc ratios compared to controls.
Exp Paradigm: Epscs were evoked by the stimulation of schaffer collateral/commissural fibers in the stratum radiatum. 10microm ifenprodil was used to block grin2b.
 Whole-cell patch clamp
 6-7 weeks
Epsp-spike relationship1
Decreased
Description: Mutants show smaller maximal depolarization of the epsp envelope and reduced epsp integral compared to controls.
Exp Paradigm: Epsps were evoked at 100hz for 1sec at a stimulation strength yielding ~2mv amplitude for the first epsp.
 Whole-cell current clamp
 6-7 weeks
Decay kinetics of miniature post synaptic currents1
Increased
Description: Mutants show significantly faster decay measured by a faster weighted tau (time constant) than controls. however, mutants show no change in time constant (tau) of nmdar mediated currents in interneurons of the hippocampal stratum oriens that retains grin2b expression, compared to controls.
Exp Paradigm: NA
 Whole-cell patch clamp
 6-7 weeks
Synaptic plasticity: hippocampal ltp1
Decreased
Description: Mutants show decreased magnitude of ltp induced by low frequency stimulation but no change in the magnitude of ltp induced by high frequency stimulation, compared to controls. mutants also show reduced charge transfer during low and high frequency ltp induction compared to controls. ltp was blocked in both mutants and controls in the presence of an nmdar antagonist (dl-ap5).
Exp Paradigm: High and low frequency stimulations of afferent fibers in stratum radiatum were used in separate paradigms.
 Whole-cell patch clamp
 6-7 weeks
Repetitive digging1
Decreased
Description: Mutants show decreased burrowing of food pellets compared to controls.
Exp Paradigm: NA
 Burrowing test
 5 months
Perseveration1
Increased
Description: Mutants show decreased spontaneous alternation in the t maze compared to controls.
Exp Paradigm: Animals received 10 trials.
 T-maze test
 5 months
Nest building behavior1
Decreased
Description: Mutants show decreased nest building capacity than controls.
Exp Paradigm: NA
 Nest building assay
 5 months
Size/growth1
Decreased
Description: Mutants show decreased body weight compared to controls.
Exp Paradigm: NA
 Body weight measurement
 Unreported
Anxiety1
Decreased
Description: Mutants show decreased anxiety compared to controls.
Exp Paradigm: Light-dark exploration test: black/white alley test
 Light-dark exploration test
 5 months
Anxiety1
Decreased
Description: Mutants show decreased anxiety compared to controls.
Exp Paradigm: Light-dark exploration test
 Light-dark exploration test
 5 months
Anxiety1
Decreased
Description: Mutants show decreased anxiety compared to controls.
Exp Paradigm: Successive alley test
 Successive alley test
 5 months
Reward reinforced choice behavior1
Decreased
Description: Mutants show decreased reward reinforced choice learning, compared to controls.
Exp Paradigm: Task floor inserts throughout the maze served as cues indicating which one of the arms was to be rewarded.
 T-maze test
 5 months
Spatial working memory1
Decreased
Description: Mutants show decrease in spatial working memory assessed by latency to escape to the visible platform, compared to controls.
Exp Paradigm: 24 training trials were performed over 9 training days.
 Morris water maze test
 5 months
Object recognition memory1
Decreased
Description: Mutants show decreased novel object recognition memory compared to controls as mutants did not show a preference for the novel object.
Exp Paradigm: Mice were exposed to two identical objects during the sample phase and to a familiar and novel object during the test phase.
 Novel object recognition test
 5 months
Spatial reference memory1
Decreased
Description: Mutants show decreased spatial reference memory assessed by time spent in the training quadrant, compared to controls.
Exp Paradigm: Probe tests were performed after removing the platform.
 Morris water maze test
 5 months
Cognitive flexibility1
Decreased
Description: Mutants show impaired spatial reversal learning compared to controls.
Exp Paradigm: Platform was moved to the opposite quadrant of the pool to assess spatial reversal learning.
 Morris water maze test
 5 months
Spatial learning1
Decreased
Description: Mutants show decreased acquisition of spatial memory measured by an increase in latency to reach the hidden platform and an increase in pathlength, compared to controls.
Exp Paradigm: NA
 Morris water maze test
 5 months
Targeted expression1
Decreased
Description: Mutants show decreased expression of grin2b protein in the whole hippocampus compared to controls (western blot). mutants show decreased grin2b mrna expression in the rostral forebrain compared to controls (ish).mutants show no change in grin2b expression in gabaergic interneurons and in the ventral hippocampus compared to controls.
Exp Paradigm: Radioactive ish was performed on coronal sections.-western blot
 Western blot
 2-4 months
Targeted expression1
Decreased
Description: Mutants show decreased expression of grin2b protein in the whole hippocampus compared to controls (western blot). mutants show decreased grin2b mrna expression in the rostral forebrain compared to controls (ish).mutants show no change in grin2b expression in gabaergic interneurons and in the ventral hippocampus compared to controls.
Exp Paradigm: Radioactive ish was performed on coronal sections.- in situ hybridization (ish)
 In situ hybridization (ish)
 2-4 months
Motor coordination and balance1
 No change
 Accelerating rotarod test
 5 months
Neuroreceptor levels: glutamate receptors: ampa receptors1
 No change
 Western blot
 2-4 months
Neuroreceptor levels: glutamate receptors: nmda receptors1
 No change
 Western blot
 2-4 months
Somatosensory cortical map architecture1
 No change
 Histology
 Adult
Action potential property: firing pattern1
 No change
 Whole-cell patch clamp
 6-7 weeks
Action potential property: firing rate1
 No change
 Whole-cell current clamp
 6-7 weeks
Action potential property: firing rate1
 No change
 Whole-cell patch clamp
 6-7 weeks
Action potential property: threshold1
 No change
 Whole-cell patch clamp
 6-7 weeks
Intrinsic membrane properties1
 No change
 Whole-cell patch clamp
 6-7 weeks
Membrane potential1
 No change
 Whole-cell patch clamp
 6-7 weeks
Miniature post synaptic current amplitude: excitatory1
 No change
 Whole-cell patch clamp
 6-7 weeks
Miniature post synaptic current frequency: excitatory1
 No change
 Whole-cell patch clamp
 6-7 weeks
Presynaptic function: paired-pulse facilitation1
 No change
 Whole-cell patch clamp
 6-7 weeks
Spontaneous post synaptic events1
 No change
 Field potential recordings
 6-7 weeks
Synaptic transmission: excitatory1
 No change
 Whole-cell patch clamp
 6-7 weeks
 Not Reported: Circadian sleep/wake cycle, Communications, Immune response, Maternal behavior, Physiological parameters, Seizure, Sensory

M_GRIN2B_6_CKO_HM

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Spontaneous movement1
Increased
Description: Mutants show increased activity compared to controls.
Exp Paradigm: NA
 Spontaneous movement analysis
 5 months
Synaptic transmission: excitatory1
Decreased
Description: Mutants showed strong reduction in sensitivity to the grin2b specific antagonist, ifenprodil, compared to controls, in the generation of nmdar mediated epscs evoked by stimulation of schaeffer collateral fibers in the stratum radiatum, indicating the functional absence of grin2b in the mutants.
Exp Paradigm: Epscs were evoked by the stimulation of schaffer collateral/commissural fibers in the stratum radiatum. 10microm ifenprodil was used to block grin2b.
 Whole-cell patch clamp
 6-7 weeks
Size/growth1
Decreased
Description: Mutants show decreased body weight compared to controls.
Exp Paradigm: NA
 Body weight measurement
 NA
Anxiety1
Decreased
Description: Mutants show decreased anxiety compared to controls.
Exp Paradigm: Successive alley test
 Successive alley test
 NA
Anxiety1
Decreased
Description: Mutants show decreased anxiety compared to controls.
Exp Paradigm: Light-dark exploration test: black/white alley test
 Light-dark exploration test
 NA
Spatial working memory1
Decreased
Description: Mutants show reduced spatial working memory assessed by latency to escape to the visible platform, compared to controls.
Exp Paradigm: 24 training trials were performed over 9 training days.-morris water maze test
 Morris water maze test
 5 months
Spatial working memory1
Decreased
Description: Mutants show reduced spatial working memory assessed by latency to escape to the visible platform, compared to controls.
Exp Paradigm: 24 training trials were performed over 9 training days.- t-maze test
 T-maze test
 5 months
Cognitive flexibility1
Decreased
Description: Mutants show impaired reversal of spatial learning compared to controls measured by a failure to show preference for the new training quadrant after the platform was moved.
Exp Paradigm: The platform was moved to the opposite quadrant followed 24 hrs. later by another probe test.
 Morris water maze test
 5 months
Targeted expression1
Decreased
Description: Mutants show decreased expression of grin2b mrna in the dorsal ca1 region and in the entire dentate gyrus of the hippocampus compared to controls (ish).
Exp Paradigm: Radioactive ish was performed on coronal sections.- histology: lacz staining
 Histology
 Adult
Targeted expression1
Decreased
Description: Mutants show decreased expression of grin2b mrna in the dorsal ca1 region and in the entire dentate gyrus of the hippocampus compared to controls (ish).
Exp Paradigm: Radioactive ish was performed on coronal sections.-in situ hybridization (ish)
 In situ hybridization (ish)
 Adult
Spatial learning1
 No change
 Morris water maze test
 5 months
Spatial reference memory1
 No change
 Morris water maze test
 5 months
Motor coordination and balance1
 No change
 Accelerating rotarod test
 5 months
 Not Reported: Circadian sleep/wake cycle, Communications, Immune response, Maternal behavior, Neuroanatomy / ultrastructure / cytoarchitecture, Physiological parameters, Repetitive behavior, Seizure, Sensory, Social behavior

M_GRIN2B_1_CKO_HM

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Dendritic architecture: spine density1
Decreased
Description: Spine density of dendrites in ca1 pyramidal neurons is significantly lower in nullizygotes compared to controls. spine head width did not differ between genotypes.
Exp Paradigm: Neurons were labeled with tungsten beads coated with dii and images were acquired using confocal microscopy.
 NA
 14-22 weeks
Synaptic plasticity1
Decreased
Description: Loss of nmdar- dependent ltd was observed in nullizygotes, while controls showed a lasting decrease in field epsp.
Exp Paradigm: NA
 Field potential recordings
 14-22 weeks
Synaptic transmission1
Abnormal
Description: The nmdar-eepsc decay time constants were twice as fast in nullizygotes.
Exp Paradigm: NA
 Whole-cell patch clamp
 14-22 weeks
Synaptic plasticity1
Decreased
Description: There was a partial deficiency in ltp in the schaffer collateral- commissural fibere in nullizygotes, in a protocol that is designed to evoke subsaturating levels of ltp.
Exp Paradigm: NA
 Field potential recordings
 14-22 weeks
Cued or contextual fear conditioning: memory of cue1
Decreased
Description: Nullizygotes froze significantly less that controls during retrieval of trace conditioned fear memory, but not delay-conditioned fear memory.
Exp Paradigm: Trace and delay fear conditioning. novel context (context discrimination)
 Fear conditioning test
 8-14 weeks
Spatial working memory1
Decreased
Description: The nullizygotes did not spontaenous alternate above chance, differed significantly with controls
Exp Paradigm: Spontaneous alternation was calculated in the t maze
 T-maze test
 8-14 weeks
Cued or contextual fear conditioning: memory of cue2
Decreased
Description: Learning was impaired in nullizygotes, compared to the floxed controls as they had increased errors, in the task that required making a choice. however simply touching a screen ( no choice) for reward was normal similar in nullizygotes compared to floxed controls
Exp Paradigm: Mice were presented with a touchscreen containing two images ( choice). touching the right (conditioned stimulus) is rewarded by food. mice are trained until they learn to pick the right image on the screen. in the 'no choice' paradigm, they only learn to touch the screen for a reward
 Fear conditioning test
 11 months
Spatial reference memory1
Decreased
Description: In the probe test the controls spent significantly more time in the platform quadrant than the nullizygotes
Exp Paradigm: Probe test
 Morris water maze test
 8-14 weeks
Cognitive flexibility2
Decreased
Description: Reversal learning was severely impaired in nullizygotes compared to floxed controls
Exp Paradigm: After discriminating the correct stimulus/ image from the incorrect one, mice are trained in the reverse manner- to test for flexibility
 Fear conditioning test
 11 months
Spatial learning1
Decreased
Description: Nullizygotes had significantly longer latencies to find the hidden platform compared to controls. in the visible platform test both genotypes performed similarly. the swimming speeds were similar between genotypes.
Exp Paradigm: Visible and hidden platform test
 Morris water maze test
 8-14 weeks
Targeted expression2
Abnormal
Description: Increasingly widespread loss of glun2b as mice age is seen under the t29-1 in the cortex
Exp Paradigm: Quantitative pcr (qrt-pcr)
 Quantitative pcr (qrt-pcr)
 Unreported
Targeted expression2
Abnormal
Description: Increasingly widespread loss of glun2b as mice age is seen under the t29-1 in the cortex
Exp Paradigm: Western blot
 Western blot
 Unreported
Synaptic plasticity2
 No change
 NA
 Unreported
 Not Reported: Circadian sleep/wake cycle, Communications, Developmental profile, Emotion, Immune response, Maternal behavior, Molecular profile, Motor phenotype, Physiological parameters, Repetitive behavior, Seizure, Sensory, Social behavior

M_GRIN2B_10_TG_HT_GRIN2A

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Social approach1
Decreased
Description: Mutants show decreased preference for a social stimulus compared to controls.
Exp Paradigm: NA
 Reciprocal social interaction test
 P1521
Targeted expression1
Decreased
Description: Mutants showed no expression of grin2b compared to controls.
Exp Paradigm: NA
 Western blot
 Unreported
Size/growth1
 No change
 Body weight measurement
 2.2 weeks
Nursing/lactation1
 No change
 General observations
 P0
 Not Reported: Circadian sleep/wake cycle, Communications, Emotion, Immune response, Learning & memory, Motor phenotype, Neuroanatomy / ultrastructure / cytoarchitecture, Neurophysiology, Physiological parameters, Repetitive behavior, Seizure, Sensory

M_GRIN2B_7_TG_HM_GRIN2A

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Spontaneous movement1
Increased
Description: Mutants show increase in spontaneous locomotion compared to controls.
Exp Paradigm: NA
 Spontaneous movement analysis
 P15-3 weeks
Neuroreceptor levels: glutamate receptors: nmda receptors1
Increased
Description: Mutants show increased expression of grin2a compared to controls (western).
Exp Paradigm: Cage transect counts were measured in a familiar setting over 3 mins.- quantitative pcr (qrt-pcr)
 Quantitative pcr (qrt-pcr)
 P17, 3 weeks
Neuroreceptor levels: glutamate receptors: nmda receptors1
Increased
Description: Mutants show increased expression of grin2a compared to controls (western).
Exp Paradigm: Cage transect counts were measured in a familiar setting over 3 mins.- histology: map2, grin1, vglut1
 Histology
 P17, 3 weeks
Neuroreceptor levels: glutamate receptors: nmda receptors1
Increased
Description: Mutants show increased expression of grin2a compared to controls (western).
Exp Paradigm: Cage transect counts were measured in a familiar setting over 3 mins.-western blot
 Western blot
 P17, 3 weeks
Decay kinetics of evoked post synaptic currents1
Abnormal
Description: Mutants showed similar outward currents with increased peak current amplitude and decreased decay time constant evoked by the application of 100microm nmda and 10microm d-serine in neurones voltage clamped at +50mv, compared to controls. these currents were sensitive to the nmdar antagonist mk801 and apv but insensitive to the glun2b selective antagonist ifenprodil and more sensitive to the zinc ion chelator tpen.
Exp Paradigm: NA
 Whole-cell patch clamp
 P17
Huddling behavior1
Decreased
Description: Mutants show a delay in returning to the social huddle compared to controls.
Exp Paradigm: NA
 Novel cage test
 P14
Social withdrawal1
Increased
Description: Mutants show increase in time spent apart from their cage mates compared to controls.
Exp Paradigm: NA
 Home cage behavior
 P15-3 weeks
Social interaction1
Decreased
Description: Mutants show less interaction with their litter mates compared to controls measured by increase in time spent isolated from their cage mates.
Exp Paradigm: NA
 General observations
 P15-3 weeks
Social approach1
Decreased
Description: Mutants show decreased preference for a social stimulus compared to controls.
Exp Paradigm: NA
 Reciprocal social interaction test
 P1521
Size/growth1
Decreased
Description: Mutants show decrease in body mass compared to controls.
Exp Paradigm: NA
 Body weight measurement
 P16
Nursing/lactation1
Decreased
Description: Mutants show decreased suckling cycles per minute compared to controls.
Exp Paradigm: Number of suckling cycles were recorded per minute.
 General observations
 P0
Signaling: mtor1
Increased
Description: Mutants show increased levels of phosphorylated p70s6k compared to controls.
Exp Paradigm: NA
 Western blot
 Unreported
Targeted expression1
Decreased
Description: Mutants showed no expression of grin2b compared to controls.
Exp Paradigm: NA
 Western blot
 P16, 3 weeks
Neuroreceptor levels: glutamate receptors: nmda receptors1
 No change
 Histology
 P17, 3 weeks
Neuroreceptor levels: glutamate receptors: nmda receptors1
 No change
 Quantitative pcr (qrt-pcr)
 P17, 3 weeks
Neuroreceptor levels: glutamate receptors: nmda receptors1
 No change
 Western blot
 P17, 3 weeks
Miniature post synaptic current amplitude: excitatory1
 No change
 Whole-cell patch clamp
 P12-16
Olfaction1
 No change
 General observations
 Unreported
Vision1
 No change
 General observations
 Unreported
Inanimate object preference1
 No change
 Reciprocal social interaction test
 P1526
 Not Reported: Circadian sleep/wake cycle, Communications, Emotion, Immune response, Learning & memory, Physiological parameters, Repetitive behavior, Seizure

M_GRIN2B_8_KO_HM

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Spontaneous movement1
Increased
Description: Mutants show increase in spontaneous locomotion compared to controls.
Exp Paradigm: NA
 Spontaneous movement analysis
 P1521
Synaptic plasticity: hippocampal ltd2
decreased
Description: stimulation of afferent fibers at 1 Hz failied to induce LTD in mutant hippocampus
 Field potential recordings
 P 2-3
Somatosensory cortical map architecture2
abnormal
Description: looking at the brainstem trigeminal complex, compared to the discernable barrelettes with 5 distinct rows of patches corresponding to 5 rows of whiskers in WT mice, mutant mice had diffuse staining and barrelette patches were missing.
 Cytochrome oxidase staining
 P 0, P 2
Anatomical projections and connectivity2
abnormal
Description: cholera toxin b labeled terminal arbors were found in the ventrolateral region of the subnucleus interpolaris of the spinal trigeminal nucleus, similar to WT mice, indicating preservation of connectivity and somatotopy of the primary afferent fibers. Although terminal arbors were distributed diffusely with no distinct clustering over the rostrocaudal axis.
Exp Paradigm: Cholera toxin B labeling
 Immunohistochemistry
 P 2
Rooting reflex2
decreased
Description: homozygous Grin2b mice were defective in the suckling response responding only with a retration of the tongue, suckling movements were scarcely observed
 Electromyogram (EMG)
 P 0
Mortality/lethality: perinatal2
Increased
Description: Homozygous GluN2B genetic knockout animals die on postnatal day 0
Exp Paradigm: Nana
 General observations
 P 0
Mortality/lethality: neonatal2
increased
Description: when homozygous mice were intervened with handfeeding, they were able to survive to the neonatal time period, there was no systematic study of low long the mice could grow in this way although one mouse survived to P 6
 General observations
 P 6
Nursing/lactation2
decreased
Description: homozygous Grin2b KO mice had no milk in their stomachs 6-7 hrs after birth and showed no suckling response after 3 days of hand feeding
 General observations
 P 0
Targeted expression2
decreased
Description: no detectable Grin2b protein in null mice
 Western blot
 P 0
Targeted expression2
decreased
Description: intact Grin2b mRNA absent in mutant mice
 In situ hybridization (ISH)
 P 0
Signaling: mtor1
Increased
Description: Mutants show increased levels of phosphorylated p70s6k compared to controls.
Exp Paradigm: NA
 Western blot
 Unreported
Cardiovascular development and function2
 no change
 General observations
 P 0
Mortality/lethality: embryonic2
 no change
 General observations
 P 0
Respiratory system development2
 no change
 General observations
 P 0
Size/growth2
 no change
 Body weight measurement
 P 0
Maternal nurturing2
 no change
 General observations
 P 0
Brain size2
 no change
 Histology
 P 0
Cortical lamination2
 no change
 Histology
 P 0
Motor neuron morphology 2
 no change
 Immunohistochemistry
 P 2
 Not Reported: Circadian sleep/wake cycle, Communications, Developmental profile, Emotion, Immune response, Learning & memory, Maternal behavior, Neuroanatomy / ultrastructure / cytoarchitecture, Neurophysiology, Physiological parameters, Repetitive behavior, Seizure, Sensory, Social behavior

M_GRIN2B_9_CKO_HM

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Social interaction1
Decreased
Description: Mutants show less interaction with their litter mates compared to controls measured by increase in time spent isolated from their cage mates.
Exp Paradigm: NA
 General observations
 P1521
Social approach1
Decreased
Description: Mutants show decreased preference for a social stimulus compared to controls.
Exp Paradigm: NA
 Reciprocal social interaction test
 P1521
Huddling behavior1
Decreased
Description: Mutants show a delay in returning to the social huddle compared to controls.
Exp Paradigm: NA
 Novel cage test
 P14
Social withdrawal1
Increased
Description: Mutants show increase in time spent apart from their cage mates compared to controls.
Exp Paradigm: NA
 Home cage behavior
 P1521
Inanimate object preference1
 No change
 Reciprocal social interaction test
 P1521
 Not Reported: Circadian sleep/wake cycle, Communications, Developmental profile, Emotion, Immune response, Learning & memory, Maternal behavior, Molecular profile, Motor phenotype, Neuroanatomy / ultrastructure / cytoarchitecture, Neurophysiology, Physiological parameters, Repetitive behavior, Seizure, Sensory

M_GRIN2B_2_CKO_HM

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Brain cytoarchitecture1
Abnormal
Description: Loss of glun2b only in the striatal cells, but not in dorsal hippocampus.
Exp Paradigm: NA
 NA
 4-6 months
Cued or contextual fear conditioning: memory of cue1
Decreased
Description: Learning was impaired in nullizygotes, compared to the floxed controls as they had increased errors, in the task that required making a choice. however simply touching a screen ( no choice) for reward was normal similar in nullizygotes compared to floxed controls
Exp Paradigm: Mice were presented with a touchscreen containing two images ( choice). touching the right (conditioned stimulus) is rewarded by food. mice are trained until they learn to pick the right image on the screen. in the 'no choice' paradigm, they only learn to touch the screen for a reward
 Fear conditioning test
 4-6 months
Cognitive flexibility1
Decreased
Description: Reversal learning was severely impaired in nullizygotes compared to floxed controls
Exp Paradigm: After discriminating the correct stimulus/ image from the incorrect one, mice are trained in the reverse manner- to test for flexibility
 Fear conditioning test
 4-6 months
 Not Reported: Circadian sleep/wake cycle, Communications, Developmental profile, Emotion, Immune response, Maternal behavior, Molecular profile, Motor phenotype, Neurophysiology, Physiological parameters, Repetitive behavior, Seizure, Sensory, Social behavior

M_GRIN2B_3_WT_ANT

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Cognitive flexibility1
Decreased
Description: However, if it was infused in the mid stages of reversal training, there were increased errors and correct choices in antagonist infused mice
Exp Paradigm: Wild type mice were first trained in a reward based discrimination task, via cued learning. in the reversal phase, cognitive flexibility was tested, as the incorrect response was interachanged with the correct response in the same reward based discrimination task.
 Fear conditioning test
 8-10 weeks
Cognitive flexibility1
 No change
 NA
 Unreported
Cognitive flexibility1
 No change
 Fear conditioning test
 8-10 weeks
 Not Reported: Circadian sleep/wake cycle, Communications, Developmental profile, Emotion, Immune response, Maternal behavior, Molecular profile, Motor phenotype, Neuroanatomy / ultrastructure / cytoarchitecture, Neurophysiology, Physiological parameters, Repetitive behavior, Seizure, Sensory, Social behavior

M_GRIN2B_8_KO_HT

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Targeted expression1
decreased
Description: Grin2b hets had about half the content of protein that WT mice had
 Western blot
 P 0
Cardiovascular development and function1
 no change
 General observations
 P 0
Mortality/lethality: embryonic1
 no change
 General observations
 P 0
Mortality/lethality: perinatal1
 no change
 General observations
 P 0
Respiratory system development1
 no change
 General observations
 P 0
Size/growth1
 no change
 Body weight measurement
 P 0
Maternal nurturing1
 no change
 General observations
 P 0
Nursing/lactation1
 no change
 General observations
 P 0
Rooting reflex1
 no change
 General observations
 P 0
 Not Reported:


Interactor Symbol Interactor Name Interactor Organism Entrez ID Uniprot ID Interaction Type Evidence Reference
ACTN2 actinin, alpha 2 88 P35609 Y2H; GST; IP/WB
Wyszynski M , et al. 1997
AP1M1 adaptor-related protein complex 1, mu 1 subunit 8907 Q59EK3 Y2H
Lavezzari G , et al. 2004
AP2M1 adaptor-related protein complex 2, mu 1 subunit 1173 Q96CW1 Y2H
Lavezzari G , et al. 2004
AP4M1 adaptor-related protein complex 4, mu 1 subunit 9179 O00189 Y2H
Lavezzari G , et al. 2004
ARHGAP32 Rho GTPase activating protein 32 9743 A7KAX9 Y2H; IP/WB; GST
Nakazawa T , et al. 2003
CAMK2A calcium/calmodulin-dependent protein kinase II alpha 815 Q9UQM7 GST; Fluorescence-based dissociation assay; in vitro kinase assay
Bayer KU , et al. 2001
CAMK2B calcium/calmodulin-dependent protein kinase II beta 816 Q13554 GST
Bayer KU , et al. 2006
CAMK2D calcium/calmodulin-dependent protein kinase II delta 817 Q13557 GST
Bayer KU , et al. 2006
CAMK2G calcium/calmodulin-dependent protein kinase II gamma 818 Q13555 GST
Bayer KU , et al. 2006
DLG1 discs, large homolog 1 (Drosophila) 1739 Q12959 Y2H
Niethammer M , et al. 1996
DLG2 discs, large homolog 2 (Drosophila) 1740 Q15700 Y2H
Irie M , et al. 1997
DLG3 discs, large homolog 3 (Drosophila) 1741 Q92796 Y2H
Irie M , et al. 1997
DLG4 DLG4discs, large homolog 4 (Drosophila) 1742 P78352 Y2H; GST
Kornau HC , et al. 1995
FYN FYN oncogene related to SRC, FGR, YES 2534 P06241 in vitro kinase assay
Wechsler A and Teichberg VI 1998
grin1 glutamate receptor, ionotropic, N-methyl D-aspartate 1 397953 Q91977 Cryo-electron microscopy; DEER spectroscopy
Zhu S , et al. 2016
GRIN3A glutamate receptor, ionotropic, N-methyl-D-aspartate 3A 116443 Q8TCU5 IP/WB
Al-Hallaq RA , et al. 2002
KDM5B lysine (K)-specific demethylase 5B 10765 Q9UGL1 Phage display
Zhou W , et al. 2009
MAGI3 membrane associated guanylate kinase, WW and PDZ domain containing 3 260425 Q5TCQ9 Y2H
Wu Y , et al. 2000
MIB2 mindbomb E3 ubiquitin protein ligase 2 142678 E9PGU1 IP/WB; in vitro binding assay
Jurd R , et al. 2007
MIR223 microRNA 223 407008 N/A Luciferase reporter assay
Harraz MM , et al. 2012
PLCG1 phospholipase C, gamma 1 5335 P19174 GST; in vitro kinase assay
Gurd JW and Bissoon N 1997
PRKCB protein kinase C, beta 5579 P05771 IP/WB
Mayadevi M , et al. 2002
PRKCG protein kinase C, gamma 5582 P05129 IP/WB
Mayadevi M , et al. 2002
PTPN5 protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched) 84867 P54829 in vitro kinase assay
Leysen JE and Pauwels PJ 1990
UBC ubiquitin C 7316 P63279 IP/WB
Jurd R , et al. 2007
Creb1 cAMP responsive element binding protein 1 12912 Q543W0 EMSA; Luciferase reporter assay
Rani CS , et al. 2005
Dapk1 death associated protein kinase 1 69635 Q80YE7 IP/WB; GST; in vitro kinase assay
Tu W , et al. 2010
DLG4 Postsynaptic density protein 95 13385 Q62108 IP; LC-MS/MS
Frank RA , et al. 2016
FMR1 fragile X mental retardation 1 14265 P35922 IP; qRT-PCR
Schtt J , et al. 2009
Fos FBJ osteosarcoma oncogene 14281 P01101 ChIP
Qiang M , et al. 2010
Fosb FBJ osteosarcoma oncogene B 14282 A2RSD4 ChIP
Qiang M , et al. 2010
Fyn Fyn proto-oncogene 14360 P39688 IP/WB
Lu W , et al. 2015
GRIN1 glutamate receptor, ionotropic, NMDA1 (zeta 1) 14810 P35438 IP/WB; IP; LC-MS/MS; Co-localization
Frank RA , et al. 2016
Il16 interleukin 16 16170 O54824 Y2H
Kurschner C and Yuzaki M 1999
Inadl InaD-like (Drosophila) 12695 Q63ZW7 GST; Y2H
Kurschner C , et al. 1998
Jun Jun oncogene 16476 P05627 ChIP
Qiang M and Ticku MK 2005
Jund Jun proto-oncogene related gene d 16478 P15066 ChIP
Qiang M and Ticku MK 2005
Map1a microtubule-associated protein 1 A 17754 Q9QYR6 IP/WB
Takei Y , et al. 2015
Mapt microtubule-associated protein tau 17762 P10637 IP/WB
Burnouf S , et al. 2012
MET met proto-oncogene 17295 P16056 IP; LC-MS/MS; Proximity ligation assay
Xie Z , et al. 2016
NF1 neurofibromatosis 1 18015 Q04690 Peptide affinity chromatography
Husi H , et al. 2000
Nfe2l2 nuclear factor, erythroid derived 2, like 2 18024 Q60795 EMSA; Supershift assay; ChIP
Priya A , et al. 2012
Nrf1 nuclear respiratory factor 1 18181 Q9WU00 EMSA; ChIP
Priya A , et al. 2012
Pik3ca phosphatidylinositol 3-kinase, catalytic, alpha polypeptide 18706 P42337 GST; IP/WB; in vitro kinase assay
Hisatsune C , et al. 2000
Ppp1r9b protein phosphatase 1, regulatory subunit 9B 217124 Q6R891 IP/WB
Baucum AJ 2nd , et al. 2012
PRKCB protein kinase C, beta 18751 P68404 Peptide affinity chromatography
Husi H , et al. 2000
Rest RE1-silencing transcription factor 19712 Q8VIG1 EMSA; Luciferase reporter assay
Qiang M , et al. 2005
Tbr1 T-box brain gene 1 21375 Q64336 Luciferase reporter assay
Wang GS , et al. 2004
Akap5 A kinase (PRKA) anchor protein 5 171026 F1LPP6 IP/WB
Lee J , et al. 2012
Atp1a1 ATPase Na+/K+ transporting subunit alpha 1 24211 P06685 IP/WB
Akkuratov EE , et al. 2014
ATP1A3 ATPase, Na+/K+ transporting, alpha 3 polypeptide 24213 P06687 IP/WB
Akkuratov EE , et al. 2014
Exoc3 exocyst complex component 3 252881 Q62825 IP/WB
Sans N , et al. 2003
Exoc4 exocyst complex component 4 116654 Q62824 IP/WB
Sans N , et al. 2003
Exoc7 exocyst complex component 7 64632 O54922 GST
Sans N , et al. 2003
Gnb2l1 guanine nucleotide binding protein (G protein), beta polypeptide 2 like 1 83427 P63245 Overlay binding assay; IP/WB
Yaka R , et al. 2002
Grin1 glutamate receptor, ionotropic, N-methyl D-aspartate 1 24408 P35439 IP/WB
Akkuratov EE , et al. 2014
Grin1 glutamate receptor, ionotropic, N-methyl D-aspartate 1 24408 P35439 IP/WB
Sheng M , et al. 1994
grin1 glutamate receptor, ionotropic, N-methyl D-aspartate 1 397953 Q91977 Cryo-electron microscopy; Co-crystal structure
Tajima N , et al. 2016
GRIN2B glutamate receptor, ionotropic, N-methyl D-aspartate 2B 24410 Q00960 IP/WB
Sheng M , et al. 1994
Il1r1 interleukin 1 receptor, type I 25663 Q05KR1 IP/WB
Gardoni F , et al. 2011
Kalrn kalirin, RhoGEF kinase 84009 P97924 IP/WB
Peng HY , et al. 2013
Lin7a lin-7 homolog a (C. elegans) 85327 Q9Z250 IP/WB
Jo K , et al. 1999
Lin7b lin-7 homolog b (C. elegans) 60377 Q9Z252 GST; Affinity chromatography
Jo K , et al. 1999
Mecp2 methyl CpG binding protein 2 (Rett syndrome) 29386 Q00566 ChIP
Lee S , et al. 2008
Nos1 nitric oxide synthase 1, neuronal 24598 P29476 IP/WB
Hu Z , et al. 2012
Ntrk2 neurotrophic tyrosine kinase, receptor, type 2 25054 Q63604 IP/WB
Carreo FR , et al. 2011
Park2 Parkinson disease (autosomal recessive, juvenile) 2, parkin 56816 Q9JK66 IP/WB
Fallon L , et al. 2001
PLAT plasminogen activator, tissue 5327 P00750 in vitro proteolysis assay
Ng KS , et al. 2012
PTEN phosphatase and tensin homolog 50557 O54857 IP/WB; in vitro binding assay
Ning K , et al. 2004
Ptpn11 protein tyrosine phosphatase, non-receptor type 11 25622 P41499 IP/WB
Lin SY , et al. 1999
Rasgrf1 RAS protein-specific guanine nucleotide-releasing factor 1 192213 P28818 Y2H; GST; IP/WB
Krapivinsky G , et al. 2003
Sgk1 serum/glucocorticoid regulated kinase 1 29517 D4A128 IP/WB
Peng HY , et al. 2013
Sptan1 spectrin, alpha, non-erythrocytic 1 64159 P16086 IP/WB; GST
Wechsler A and Teichberg VI 1998
Src v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) 83805 Q9JJ10 GST
Takagi N , et al. 1999
Syngap1 synaptic Ras GTPase activating protein 1 192117 D3ZCL8 IP/WB
Chen HJ , et al. 1998
Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 311055 Q6F6B3 IP/WB
Suzuki T , et al. 2005
Trpv1 transient receptor potential cation channel, subfamily V, member 1 83810 O35433 IP/WB
Lee J , et al. 2012

HELP
Copyright © 2017 MindSpec, Inc.